Patent US2764862A successfully refreshed from Google Patents.
Patent US2324262A successfully refreshed from Google Patents.
Patent US1735356A successfully refreshed from Google Patents.
← Back to Patent Explorer
US7585321B2 Expired / Lapsed US ⏱️ 0.0 years remaining

Methods of implanting a prosthetic heart valve within a native heart valve

Assignee: Edwards Lifesciences PVT Inc
•
Filing: 2005-05-27
•
Granted: 2009-09-08
•
Expires: 2025-05-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A valve prosthesis which is especially useful in the case of aortic stenosis and capable of resisting the powerful recoil force and to stand the forceful balloon inflation performed to deploy the valve and to embed it in the aortic annulus, comprises a collapsible valvular structure and an expandable frame on which said valvular structure is mounted. The valvular structure is composed of physiologically compatible valvular tissue that is sufficiently supple and resistant to allow the valvular structure to be deformed from a closed state to an opened state. The valvular tissue forms a continuous surface and is provided with strut members that create stiffened zones which induce the valvular structure to follow a patterned movement in its expansion to its opened state and in its turning back to its closed state.

Inventors

  • 👤 Alain Cribier

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 23:30
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2409; A61F2/2412; A61F2/2415; A61F2/2418; A61F2/2427; A61F2/243; A61F2/2433; A61B; A61B90/00; A61B90/39; A61F2/2475; A61F2220/00; A61F2220/0008; A61F2230/00; A61F2230/0002; A61F2230/0028; A61F2230/0054; A61F2230/0063; A61F2230/0069; A61F2250/00; A61F2250/0058; A61F2250/006; Y; Y10; Y10S; Y10S623/00; Y10S623/90; Y10S623/902; Y10S623/904

Claims Analysis

Total Claims: 29
Claim 1
Independent Claim 157 words
A method of implanting a prosthetic heart valve in a patient, comprising: providing a two-part heart valve, each part being expandable from a compressed state, a first part comprising an external scaffolding frame expandable into a substantially cylindrical shape having an interior surface defining an opening, and a second part comprising a collapsible valvular structure fastened within an internal frame, the valvular structure comprising valve leaflets formed of a biological material; delivering the external scaffolding frame in its compressed state to an annulus of a native semi-lunar heart valve in a human heart; expanding the external scaffolding frame into an expanded state to secure the external scaffolding frame within the annulus of the native semi-lunar heart valve; delivering the second part to within the opening of the expanded external scaffolding frame; and expanding the internal frame against the interior surface of the external scaffolding frame such that the internal frame is fixed to the external scaffolding frame.
Claim 2
Independent Claim 157 words
A method of implanting a prosthetic heart valve in a patient, comprising: providing a two-part heart valve, each part being expandable from a compressed state, a first part comprising an external scaffolding frame expandable into a substantially cylindrical shape having an interior surface defining an opening, and a second part comprising a collapsible valvular structure fastened within an internal frame, the valvular structure comprising valve leaflets formed of a biological material; delivering the external scaffolding frame in its compressed state to an annulus of a native semi-lunar heart valve in a human heart; expanding the external scaffolding frame into an expanded state to secure the external scaffolding frame within the annulus of the native semi-lunar heart valve; delivering the second part to within the opening of the expanded external scaffolding frame; and expanding the internal frame against the interior surface of the external scaffolding frame such that the internal frame is fixed to the external scaffolding frame.
Claim 3
Dependent Claim 29 words
The method of claim 1 , wherein delivering the external scaffolding frame to the annulus includes advancing the external scaffolding frame via a catheter introduced into a femoral artery.
Claim 4
Dependent Claim 28 words
The method of claim 2 , further including gaining access to the femoral artery using an arterial introducer having a size of 18 F (5.7 mm) or less.
Claim 5
Dependent Claim 13 words
The method of claim 1 , wherein the external scaffolding frame is balloon-expandable.
Claim 6
Dependent Claim 18 words
The method of claim 1 , wherein both the first and second parts are expanded using separate balloons.
Claim 7
Dependent Claim 22 words
The method of claim 5 , wherein both balloons for expanding the first and second parts are located on a single catheter.
Claim 8
Independent Claim 157 words
A method of implanting a prosthetic heart valve within a native aortic valve, comprising: inflating a balloon to dilate the native aortic valve; delivering a balloon-expandable external scaffolding stent in a compressed state to an annulus of the native aortic valve, the external scaffolding stent comprising a grate shaped frame forming a substantially cylindrical structure having an interior surface defining an opening; expanding the external scaffolding stent into an expanded state within the dilated native aortic valve for contacting the leaflets of the native aortic valve and maintaining the native aortic valve in a dilated condition; delivering a collapsible valvular structure fastened within an internal stent to a location within the expanded external scaffolding stent, the valvular structure comprising valve leaflets formed of a biological material; and expanding the internal stent against the interior surface of the external scaffolding stent to form the prosthetic heart valve, wherein the internal stent is fixed to the external scaffolding stent.
Claim 9
Independent Claim 157 words
A method of implanting a prosthetic heart valve within a native aortic valve, comprising: inflating a balloon to dilate the native aortic valve; delivering a balloon-expandable external scaffolding stent in a compressed state to an annulus of the native aortic valve, the external scaffolding stent comprising a grate shaped frame forming a substantially cylindrical structure having an interior surface defining an opening; expanding the external scaffolding stent into an expanded state within the dilated native aortic valve for contacting the leaflets of the native aortic valve and maintaining the native aortic valve in a dilated condition; delivering a collapsible valvular structure fastened within an internal stent to a location within the expanded external scaffolding stent, the valvular structure comprising valve leaflets formed of a biological material; and expanding the internal stent against the interior surface of the external scaffolding stent to form the prosthetic heart valve, wherein the internal stent is fixed to the external scaffolding stent.
Claim 10
Dependent Claim 26 words
The method of claim 7 , wherein delivering the external scaffolding stent includes advancing the external scaffolding stent via a catheter introduced into a femoral artery.
Claim 11
Dependent Claim 20 words
The method of claim 7 , wherein both the external scaffolding stent and valvular structure are expanded using separate balloons.
Claim 12
Dependent Claim 35 words
The method of claim 9 , wherein the external scaffolding stent is stronger than the internal stent such that a higher balloon pressure is required to expand the external scaffolding stent than the internal stent.
Claim 13
Independent Claim 234 words
A method of treating aortic stenosis in a human heart, comprising: inserting a balloon catheter through an opening in a femoral artery; percutaneously advancing the balloon catheter through an aorta in a retrograde direction to a location within a native aortic valve; inflating a balloon disposed on the distal end portion of the balloon catheter to dilate stenosed leaflets of the native aortic valve; deflating the balloon and withdrawing the balloon catheter from the native aortic valve; inserting a delivery catheter through the opening in the femoral artery, the delivery catheter having a prosthetic heart valve disposed along a distal end portion thereof; percutaneously advancing the delivery catheter through the aorta in the retrograde direction until the prosthetic heart valve is located within the native aortic valve; and radially expanding the prosthetic heart valve such that the prosthetic heart valve contacts the stenosed leaflets of the native aortic valve; wherein the prosthetic heart valve comprises a collapsible support structure and a collapsible valvular structure coupled to the support structure, the valvular structure comprising leaflets formed of a biological material for occluding blood flow in one direction, the prosthetic heart valve further comprising an internal cover extending at least from an inlet end of the support structure to the valvular structure, the internal cover configured for preventing regurgitation through the support structure after the prosthetic heart valve is radially expanded within the native aortic valve.
Claim 14
Independent Claim 234 words
A method of treating aortic stenosis in a human heart, comprising: inserting a balloon catheter through an opening in a femoral artery; percutaneously advancing the balloon catheter through an aorta in a retrograde direction to a location within a native aortic valve; inflating a balloon disposed on the distal end portion of the balloon catheter to dilate stenosed leaflets of the native aortic valve; deflating the balloon and withdrawing the balloon catheter from the native aortic valve; inserting a delivery catheter through the opening in the femoral artery, the delivery catheter having a prosthetic heart valve disposed along a distal end portion thereof; percutaneously advancing the delivery catheter through the aorta in the retrograde direction until the prosthetic heart valve is located within the native aortic valve; and radially expanding the prosthetic heart valve such that the prosthetic heart valve contacts the stenosed leaflets of the native aortic valve; wherein the prosthetic heart valve comprises a collapsible support structure and a collapsible valvular structure coupled to the support structure, the valvular structure comprising leaflets formed of a biological material for occluding blood flow in one direction, the prosthetic heart valve further comprising an internal cover extending at least from an inlet end of the support structure to the valvular structure, the internal cover configured for preventing regurgitation through the support structure after the prosthetic heart valve is radially expanded within the native aortic valve.
Claim 15
Dependent Claim 22 words
The method of claim 11 , wherein the support structure comprises a stent and the valvular structure is sutured to the stent.
Claim 16
Dependent Claim 16 words
The method of claim 12 , wherein the valvular structure comprises tissue from a pig heart.
Claim 17
Dependent Claim 13 words
The method of claim 12 , wherein the valvular structure comprises bovine pericardium.
Claim 18
Dependent Claim 22 words
The method of claim 12 , wherein the support structure is a stent and the internal cover is attached to the stent.
Claim 19
Dependent Claim 17 words
The method of claim 15 , wherein the internal cover and the valvular structure are integrally attached.
Claim 20
Dependent Claim 21 words
The method of claim 16 , wherein the internal cover and the valvular structure are formed of the same biological material.
Claim 21
Dependent Claim 13 words
The method of claim 17 , wherein the biological material is pericardial tissue.
Claim 22
Dependent Claim 19 words
The method of claim 18 , wherein the internal cover and the valvular structure are sutured to the stent.
Claim 23
Dependent Claim 24 words
The method of claim 11 , wherein the internal cover extends only from the inlet end of the support structure to the valvular structure.
Claim 24
Dependent Claim 17 words
The method of claim 11 , wherein the collapsible support structure is made of a metallic material.
Claim 25
Dependent Claim 15 words
The method of claim 21 , wherein the metallic material forms a grate type structure.
Claim 26
Dependent Claim 15 words
The method of claim 11 , wherein the collapsible support structure has a concave profile.
Claim 27
Dependent Claim 23 words
The method of claim 11 , wherein the prosthetic heart valve is radially expanded by inflating a balloon within the prosthetic heart valve.
Claim 28
Independent Claim 271 words
A method of treating aortic stenosis in a human heart, comprising: inserting a balloon catheter through an opening in a femoral artery; percutaneously advancing the balloon catheter through an aorta in a retrograde direction to a location within a native aortic valve; inflating a balloon disposed on the distal end portion of the balloon catheter to dilate stenosed leaflets of the native aortic valve; deflating the balloon and withdrawing the balloon catheter from the native aortic valve; inserting a delivery catheter through the opening in the femoral artery, the delivery catheter having a prosthetic heart valve disposed along a distal end portion thereof; percutaneously advancing the delivery catheter through the aorta in the retrograde direction until the prosthetic heart valve is located within the native aortic valve; and radially expanding the prosthetic heart valve such that the prosthetic heart valve contacts the stenosed leaflets of the native aortic valve; wherein the prosthetic heart valve comprises a collapsible metallic grate type stent and a collapsible valvular structure coupled to and located within the stent, the valvular structure comprising leaflets formed of a biological material for occluding blood flow in one direction, the prosthetic heart valve further comprising an internal cover attached to an interior surface of the stent and extending from the valvular structure toward an inlet end of the stent for preventing passage of blood through spaces between bars of the stent along a lower part of the stent while allowing blood to pass through spaces between bars of the stent along an upper part of the stent after the prosthetic heart valve is radially expanded within the native aortic valve.
Claim 29
Independent Claim 271 words
A method of treating aortic stenosis in a human heart, comprising: inserting a balloon catheter through an opening in a femoral artery; percutaneously advancing the balloon catheter through an aorta in a retrograde direction to a location within a native aortic valve; inflating a balloon disposed on the distal end portion of the balloon catheter to dilate stenosed leaflets of the native aortic valve; deflating the balloon and withdrawing the balloon catheter from the native aortic valve; inserting a delivery catheter through the opening in the femoral artery, the delivery catheter having a prosthetic heart valve disposed along a distal end portion thereof; percutaneously advancing the delivery catheter through the aorta in the retrograde direction until the prosthetic heart valve is located within the native aortic valve; and radially expanding the prosthetic heart valve such that the prosthetic heart valve contacts the stenosed leaflets of the native aortic valve; wherein the prosthetic heart valve comprises a collapsible metallic grate type stent and a collapsible valvular structure coupled to and located within the stent, the valvular structure comprising leaflets formed of a biological material for occluding blood flow in one direction, the prosthetic heart valve further comprising an internal cover attached to an interior surface of the stent and extending from the valvular structure toward an inlet end of the stent for preventing passage of blood through spaces between bars of the stent along a lower part of the stent while allowing blood to pass through spaces between bars of the stent along an upper part of the stent after the prosthetic heart valve is radially expanded within the native aortic valve.

References Cited (Backward Citations)

US3143742A Cited
US3409013A Cited
US3587115A Cited
US3548417A Cited
US3671979A Cited
US3657744A Cited
US3714671A Cited
US3755823A Cited
DE2246526C3 Cited
US3997923A Cited
US4035849A Cited
US4106129A Cited
US4056854A Cited
US4297749A Cited
US4222126A Cited
US4265694A Cited
US4574803A Cited
US4343048A Cited
GB2056023B Cited
US4373216A Cited
US4339831A Cited
US4470157A Cited
US4345340A Cited
US4406022A Cited
US4655771A Cited
US4655771B1 Cited
US4484579A Cited
US4680031A Cited
US4605407A Cited
US4535483A Cited
US4705516A Cited
US4612011A Cited
EP0144167B1 Cited
US4787899A Cited
US5026366A Cited
US4592340A Cited
US4979939A Cited
US4787901A Cited
US4643732A Cited
SU1271508A1 Cited
US4759758A Cited
US4733665B1 Cited
US4733665C2 Cited
US4733665A Cited
US4922905A Cited
US4692164A Cited
US4878906A Cited
US4790843A Cited
US4777951A Cited
US4883458A Cited
US4878495A Cited
US4796629A Cited
US4829990A Cited
US4851001A Cited
US5159937A Cited
US4909252A Cited
US5032128A Cited
US5080668A Cited
US5007896A Cited
US4856516A Cited
US4966604A Cited
US4994077A Cited
US5609626A Cited
US5500014A Cited
US5047041A Cited
US4986830A Cited
US5089015A Cited
US5141494A Cited
US5037434A Cited
US5059177A Cited
US6168614B1 Cited
US5840081A Cited
WO1991017720A1 Cited
US5085635A Cited
US5411552A Cited
US20030069492A1 Cited
US5152771A Cited
US5282847A Cited
US5607464A Cited
US5360444A Cited
US5295958A Cited
US5443446A Cited
WO1992017118A1 Cited
US5167628A Cited
US5397351A Cited
WO1993001768A1 Cited
EP0597967B1 Cited
US6866650B2 Cited
US20040225355A1 Cited
US5545214A Cited
US5370685A Cited
US5769812A Cited
US5756476A Cited
US5163953A Cited
US5332402A Cited
US5549665A Cited
US6872223B2 Cited
US5545209A Cited
US5480424A Cited
US6302906B1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2012-09-07 2013-03-09 2013-09-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2016-09-07 2017-03-09 2017-09-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2020-09-07 2021-03-09 2021-09-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag